SCHEMBL33323

SCHEMBL33323

CN1CCN(C2=c3ccccc3=Nc3ccc(Cl)cc3N2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.51
DRD4 P21917 8/20 0.51
CHRM1 P11229 4/20 0.51
DRD3 P35462 4/20 0.51
HRH4 Q9H3N8 8/20 0.48
HRH1 P35367 4/20 0.48
DRD1 P21728 4/20 0.48
HRH2 P25021 3/20 0.48
CHRM2 P08172 3/20 0.48
HTR1A P08908 3/20 0.48
ADRA2A P08913 3/20 0.48
ADRA2B P18089 3/20 0.48
ADRA2C P18825 3/20 0.48
CHRM3 P20309 3/20 0.48
SLC6A2 P23975 3/20 0.48
HTR2A P28223 3/20 0.48
HTR2C P28335 3/20 0.48
SLC6A4 P31645 3/20 0.48
ADRA1A P35348 3/20 0.48
OPRD1 P41143 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7853611 0.98 DRD2 (0.49) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL10108539 0.87 HRH4 (0.44) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL18639828 0.87 DRD2 (0.41) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL678149 0.87 DRD2 (0.47) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL17471629 0.86 HTR3E (0.44) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL11929339 0.82 DRD2 (0.35) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL11929726 0.75 DRD2 (0.47) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL21887284 0.73 DRD2 (0.43) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL26598838 0.73 DRD2 (0.43) DRD2DRD4CHRM1DRD3HRH4
SCHEMBL11925296 0.71 DRD2 (0.42) DRD2DRD4CHRM1DRD3HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5415 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607938-B1 PHARMACEUTICAL COMPOSITION SOVIC BRKICIC LJILJANA (HR) 2026-05-27 EP claimed
CN-122079853-A N-substituted indoles and other heterocyclic compounds for the treatment of brain diseases 2026-05-26 CN claimed
EP-4615820-B1 CRYSTALLINE FORMS OF EVENAMIDE NEWRON PHARM SPA (IT) 2026-02-04 EP claimed
EP-3507371-B1 COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM UNIV RUTGERS (US) 2026-01-28 EP claimed
EP-4049681-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF NEUROCRINE BIOSCIENCES INC (US) 2026-01-07 EP claimed
EP-3931189-B1 AZEPINO-INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS UNIV CALIFORNIA (US) 2025-12-24 EP claimed
US-20250382291-A1 SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR SUPPRESSING TOXIC ENDOPLASMIC RETICULUM STRESS UNIV COLUMBIA (US) 2025-12-18 US claimed
EP-3258950-B1 ALZHEIMER ABETA PEPTIDE BINDING POLYPEPTIDE AMYLONIX AB (SE) 2025-10-29 EP claimed
EP-3747358-B1 USE OF ELECTRORETINOGRAPHY (ERG) FOR THE ASSESSMENT OF PSYCHIATRIC DISORDERS UNIV LAVAL (CA) 2025-10-15 EP claimed
US-20250177422-A1 CO-ADMINISTRATION OF A CO-CRYSTAL OF PSILOCYBIN AND PSILOCIN WITH AN ATYPICAL ANTIPSYCHOTIC Zylorion Health Inc. (CA) 2025-06-05 US claimed
EP-1089788-B1 SONOPHORESIS APPARATUS 3M INNOVATIVE PROPERTIES CO (US) 2003-10-01 EP claimed
WO-2003070978-A1 METHOD FOR IDENTIFYING SIDE-EFFECT RELEVANT GENETIC MARKER PROFILES DAHMEN NORBERT (DE) 2003-08-28 WO claimed
EP-1274405-A2 TRANSDERMAL OR TRANSMUCOSAL DOSAGE FORMS WITH A NICOTINE-CONTAINING ACTIVE SUBSTANCE COMBINATION FOR SMOKER DISINTOXICATION LTS Lohmann Therapie-Systeme AG (DE) 2003-01-15 EP claimed
US-20020035057-A1 Treatment of movement disorders by administration of 5-hydroxytryptamine receptor/alpha2 adrenergic receptor antagonist compositions RICHTER VIRGINIA PACT (US) 2002-03-21 US claimed
WO-2001080837-A2 TRANSDERMAL OR TRANSMUCOSAL DOSAGE FORMS WITH A NICOTINE-CONTAINING ACTIVE SUBSTANCE COMBINATION FOR SMOKER DISINTOXICATION LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2001-11-01 WO claimed
EP-0574406-B1 HUMAN DOPAMINE D4 RECEPTOR AND ITS USES OREGON STATE (US) 2000-10-11 EP claimed
EP-0669128-B1 SUSTAINED-RELEASE MICROSPHERE CONTAINING ANTIPSYCHOTIC AND PROCESS FOR PRODUCING THE SAME YOSHITOMI PHARMACEUTICAL (JP) 2000-01-05 EP claimed
EP-0668912-B1 THE St-B17 SEROTONIN RECEPTOR US HEALTH (US) 1999-12-15 EP claimed
EP-0428754-B1 HAIR GROWTH STIMULANT SHISEIDO CO LTD (JP) 1994-05-25 EP claimed
EP-0174342-B1 BRAIN-SPECIFIC ANALOGUES OF CENTRALLY ACTING AMINES UNIVERSITY OF FLORIDA (US) 1989-12-20 EP claimed